METHOD FOR IMPROVING CLINICAL COURSE OF POSTOPERATIVE PERIOD IN PATIENTS WITH VENTRAL HERNIAS Russian patent published in 2013 - IPC A61B5/08 A61B17/04 A61K31/05 A61K31/19 A61P43/00 A61M15/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to surgery and pulmonology, and may be used to improve the clinical course of the postoperative period in the patients with ventral hernias. A cough limit is determined one week before the operation. That is ensured by nebuliser inhalations of citric acid solutions in increasing concentrations into patient's airways by 5-second slow inhalation after maximum exhalations for three times every 10 seconds. The inhalation is continued till observing five and more coughs running or if achieving the highest concentration of the solution. The sensitivity threshold of the cough receptors is considered to be the maximum concentration of the citric acid solution causing 5 and more coughs, in case the solution inhalation with the further concentration also causes coughing. If the cough limit makes 2.5 g/l and lower, high sensitivity of the cough receptors is stated. That required the postoperative administration of the preparation indicated for the antitussive therapy, e.g. Stoptussin 1 tablet 3 times a day, at least 5 days before the operation and for 7 days after. If the cough limit makes 2.6 to 10 g/l, moderate sensitivity of the cough receptors is concluded. In this case, Soptussin is administered in a dose of 1 tablet 2 times a day 3 days before the surgical management and for 5 days thereafter. If the cough limit makes 10 g/l and more, lower sensitivity of the cough receptors in the person being tested is stated, and no antitussive preparations prescribed.

EFFECT: method provides higher therapeutic quality in ventral hernias ensured by prevented development of postoperative coughing.

2 ex